subscribeSubscribe
3D modelling of hip DXA reveals improvements in bone density of romosozumab

3D modelling of hip DXA reveals improvements in bone density of romosozumab
UCB
09 Sep 2022
Share Share
Romosozumab substantially builds bone density in hip and spine

Romosozumab substantially builds bone density in hip and spine
EUREKALERT
11 Nov 2020
Share Share
Romosozumab for the treatment of osteoporosis

Romosozumab for the treatment of osteoporosis
SCIENCEDIRECT
15 Jun 2020
Share Share
UCB Shares Breadth of Innovative New Data from Rheumatology for EULAR 2020

UCB Shares Breadth of Innovative New Data from Rheumatology for EULAR 2020
UCB
04 Jun 2020
Share Share
Amgen studying Otezla for coronavirus, Q1 results beat estimates

Amgen studying Otezla for coronavirus, Q1 results beat estimates
PRESS RELEASE
02 May 2020
Share Share
Amgen EVENITY (Romosozumab-aqqg Injection) Receives Supplemental Approval in US

Amgen EVENITY (Romosozumab-aqqg Injection) Receives Supplemental Approval in US
FDA
21 Dec 2019
Share Share
UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe
Phil Taylor PMLIVE
13 Dec 2019
Share Share
CHMP U-turn for Evenity

CHMP U-turn for Evenity
Anna Smith PHARMATIMES
19 Oct 2019
Share Share
EVENITY® (Romosozumab) Receives Positive CHMP Opinion

EVENITY® (Romosozumab) Receives Positive CHMP Opinion
PR NEWSWIRE
17 Oct 2019
Share Share
EMA’s CHMP Rejects Another Drug Approved by US FDA

EMA’s CHMP Rejects Another Drug Approved by US FDA
Zachary Brennan RAPS
01 Jul 2019
Share Share